Get started
Author

Judith Lafleur

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial
2020 · Jacobus Pfisterer, Catherine M Shannon, et al. · The Lancet Oncology · 171
PDF
Prognostic Value of Serum Creatinine Levels in Patients with Epithelial Ovarian Cancer
2018 · JUDITH LAFLEUR, KATRIN HEFLER-FRISCHMUTH, et al. · Anticancer Research · 27
PDF
Risk of endometrial cancer in asymptomatic postmenopausal patients with thickened endometrium: data from the FAME-Endo study: an observational register study
2018 · Lukas Hefler, Judith Lafleur, et al. · Archives of Gynecology and Obstetrics · 22
Plasma fibrinogen levels in patients with benign and malignant ovarian tumors
2015 · Katrin Hefler-Frischmuth, Judith Lafleur, et al. · Gynecologic Oncology · 18
Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors—Results of Expression VI–Carolin Meets HANNA–Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey
2023 · Hannah Woopen, Maren Keller, et al. · Cancers · 13
PDF
Double-loaded mature dendritic cell (DC) therapy for non-HLA-restricted patients with advanced ovarian cancer: Final results of a clinical phase I study.
2013 · Marianne Imhof, Markus Lipovac, et al. · Journal of Clinical Oncology · 8
Compartment syndrome after gynecologic laparoscopy: systematic review of the literature and establishment of normal values for postoperative serum creatine kinase and myoglobin levels
2017 · Katrin Hefler-Frischmuth, Judith Lafleur, et al. · Archives of Gynecology and Obstetrics · 7
23P Enriching for response: Patient selection criteria for A2AR inhibition by EXS-21546 through ex vivo modelling in primary patient material
2022 · G. Vladimer, I. Alt, et al. · Immuno-Oncology Technology · 4
Loop electrosurgical excision procedure (LEEP) under local anesthesia: a retrospective analysis of 435 subsequent cases under a quality assurance program
2025 · Ulrike Binder, Alice Wenzl, et al. · Archives of Gynecology and Obstetrics · 2
PDF
Fatigue in long-term survivors with ovarian cancer: Results of Expression VI – Carolin meets HANNA – Holistic analysis of Long-term survival with ovarian cancer—The international NOGGO, ENGOT and GCIG survey.
2020 · Hannah Woopen, Maren Keller, et al. · Journal of Clinical Oncology · 2
Patients with endometrial cancer: Expectations and preferences towards therapy and quality of life—First results of an international survey (NOGGO, ENGOT, GCIG - IMPROVE/EXPRESSION XI).
2023 · Lukas Chinczewski, Catherine Krause, et al. · Journal of Clinical Oncology · 1
Abstract 4150: Enriching for adenosine antagonist patient responses through deep learning
2022 · Isabella Alt, Robert Shelke, et al. · Cancer Research · 1
One-stop clinical assessment of risk for endometrial hyperplasia (OSCAR-Endo): a fast-track protocol for evaluating endometrial pathologies
2017 · Katrin Hefler-Frischmuth, Elisabeth Hirtl-Goergl, et al. · Archives of Gynecology and Obstetrics · 1
Die Zufriedenheit von Assistent:innen mit ihrer Ausbildung an zertifizierten gynäko-onkologischen Abteilungen in Österreich – eine Analyse öffentlich zugänglicher Daten
2026 · H Wintersteller-Fickert, M Patzak, et al. · Geburtshilfe und Frauenheilkunde
Symptomatische vs. asymptomatische Patientinnen mit gynäkologischen Malignomen
2025 · M Patzak, U Binder, et al. · Geburtshilfe und Frauenheilkunde
Abstract 4956: Discovering novel targetable pathways by combining functional and multi-omic data from primary ovarian cancer samples
2023 · Irene Gutierrez-Perez, Bekir Ergüner, et al. · Cancer Research
Abstract 2151: Identification of transcript adenosine fingerprint to enrich for A2AR and PD-1 inhibition responders
2023 · Isabella Alt, Robert Sehlke, et al. · Cancer Research
Abstract 1893: Deep learning supported high content analysis of primary patient samples identifies ALK inhibition as a novel mechanism of action in a subset of ovarian cancers
2022 · Irene Gutierrez-Perez, Joost Van Ham, et al. · Cancer Research
Der minimalinvasive Zugangsweg zur Behandlung des Endometriumkarzinoms gilt als Qualitätsparameter
2022 · B Bergmeister, F Roithmeier, et al. · Geburtshilfe und Frauenheilkunde
Abstract 1303: AI driven single cell analysis of drug action in solid tumor material: An entry point to functional precision medicine
2021 · Valentin Aranha, Diogo Tomaz, et al. · Cancer Research
Abstract 5233: Towards patient-centric drug discovery: Analyzing drug action in malignant pleural effusions and ascites using high content imaging and deep learning
2020 · Robert Sehlke, Christina Taubert, et al. · Cancer Research
Towards patient-centric drug discovery: Drug action in malignant pleural effusions and ascites using high content imaging and deep learning.
2020 · Nikolaus Krall, Robert Sehlke, et al. · Journal of Clinical Oncology
Works count: 22
Citation count: 277
H-index: 7
I10-index: 5
Year
Topic
Type